Concepedia

Bénédicte Lallemand

BL

Statistics

Publications

13

Citations

717

H-Index

12

Active since

2002

Affiliations

UCB Pharma (Belgium)(Current)

University of Liège

UCB Pharma (United Kingdom)

Seabrook

Addex Therapeutics (Switzerland)

Bénédicte Lallemand is an author at UCB Pharma (Belgium) specializing in medicinal chemistry, drug discovery, and pharmacy.

Publications per year

2002–2020

13

Publications

13

Discovery of 4-Substituted Pyrrolidone Butanamides as New Agents with Significant Antiepileptic Activity

Benoît Kenda, Alain Matagne, Patrice Talaga et al. · Journal of Medicinal Chemistry · 2003 · 225 citations · Full text

, , +13

Late‐Stage <sup>18</sup>F‐Difluoromethyl Labeling of N‐Heteroaromatics with High Molar Activity for PET Imaging

Laura Trump, Agostinho Lemos, Bénédicte Lallemand et al. · Angewandte Chemie International Edition · 2019 · 87 citations · Full text

, , +16

Direct sulfonylation of anilines mediated by visible light

Tarn C. Johnson, Bryony L. Elbert, Alistair J. M. Farley et al. · Chemical Science · 2017 · 73 citations · Full text

, , +7

First dual NK1 antagonists–serotonin reuptake inhibitors: synthesis and SAR of a new class of potential antidepressants

Thomas Ryckmans, Laurent Balançon, Olivier Berton et al. · Bioorganic & Medicinal Chemistry Letters · 2002 · 69 citations · Full text

, , +17

Discovery of Heterocyclic Nonacetamide Synaptic Vesicle Protein 2A (SV2A) Ligands with Single‐Digit Nanomolar Potency: Opening Avenues towards the First SV2A Positron Emission Tomography (PET) Ligands

Joël Mercier, Laurence Archen, Véronique Bollu et al. · ChemMedChem · 2014 · 68 citations

, , +17

1–5 of 13